Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
January 02, 2020 08:14 ET
|
Amarantus Bioscience Holdings, Inc.
Emerald gains exclusive worldwide development rights to ESS, MANF and PhenoGuard Amarantus receives Emerald preferred stock valued at a minimum of $66.6 million New York, NY, Jan. 02,...